GLP-1 receptors - the drugs behind Ozempic and Mounjaro - could have great benefits for colon cancer patients, the study ...
Medications called SGLT2 inhibitors lower blood sugar in people with type 2 diabetes. And new research suggests these drugs may have an added benefit -- lowering the risk of gout. Compared with people ...
Researchers looked specifically at head-to-head randomized clinical trials of next-in-class cancer drugs against existing agents in the same class. Less than one-quarter of next-in-class cancer drugs ...
Imagine reaching for your daily medication, only to learn it could be putting your health at risk. That's the reality facing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results